Stay updated with breaking news from While Laboratory Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cypress Capital Group lessened its holdings in Laboratory Co. of America Holdings (NYSE:LH - Get Rating) by 12.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,338 shares of the medical research company's s
Los Angeles Capital Management LLC cut its holdings in shares of Laboratory Co. of America Holdings (NYSE:LH - Get Rating) by 2.6% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 144,900 shares of the medical research c
Robert W. Baird lifted their price objective on shares of Laboratory Co. of America from $270.00 to $285.00 in a research note on Wednesday.
Laboratory Co. of America Holdings (NYSE:LH - Get Rating) was the recipient of a significant decline in short interest during the month of December. As of December 15th, there was short interest totalling 1,550,000 shares, a decline of 13.4% from the November 30th total of 1,790,000 shares. Currently, 1.8% of the company's stock are sold short. Based on an average daily trading volume, of 788,400 shares, the days-to-cover ratio is currently 2.0 days.
Laboratory Co. of America Holdings (NYSE:LH - Get Rating) has been given a consensus rating of "Moderate Buy" by the eleven analysts that are presently covering the stock, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a hold recommendation and five have assig